BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32909611)

  • 1. ATG16L1 negatively regulates RICK/RIP2-mediated innate immune responses.
    Honjo H; Watanabe T; Arai Y; Kamata K; Minaga K; Komeda Y; Yamashita K; Kudo M
    Int Immunol; 2021 Jan; 33(2):91-105. PubMed ID: 32909611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOD2 downregulates colonic inflammation by IRF4-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6.
    Watanabe T; Asano N; Meng G; Yamashita K; Arai Y; Sakurai T; Kudo M; Fuss IJ; Kitani A; Shimosegawa T; Chiba T; Strober W
    Mucosal Immunol; 2014 Nov; 7(6):1312-25. PubMed ID: 24670424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RICK/RIP2 is a NOD2-independent nodal point of gut inflammation.
    Watanabe T; Minaga K; Kamata K; Sakurai T; Komeda Y; Nagai T; Kitani A; Tajima M; Fuss IJ; Kudo M; Strober W
    Int Immunol; 2019 Sep; 31(10):669-683. PubMed ID: 31132297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems.
    Kobayashi K; Inohara N; Hernandez LD; Galán JE; Núñez G; Janeway CA; Medzhitov R; Flavell RA
    Nature; 2002 Mar; 416(6877):194-9. PubMed ID: 11894098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation.
    Hasegawa M; Fujimoto Y; Lucas PC; Nakano H; Fukase K; Núñez G; Inohara N
    EMBO J; 2008 Jan; 27(2):373-83. PubMed ID: 18079694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1.
    Zhao Y; Alonso C; Ballester I; Song JH; Chang SY; Guleng B; Arihiro S; Murray PJ; Xavier R; Kobayashi KS; Reinecker HC
    Inflamm Bowel Dis; 2012 Apr; 18(4):603-12. PubMed ID: 21887730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIP6 is a RIP2-associated common signaling component of multiple NF-kappaB activation pathways.
    Li L; Bin LH; Li F; Liu Y; Chen D; Zhai Z; Shu HB
    J Cell Sci; 2005 Feb; 118(Pt 3):555-63. PubMed ID: 15657077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protein ATG16L1 suppresses inflammatory cytokines induced by the intracellular sensors Nod1 and Nod2 in an autophagy-independent manner.
    Sorbara MT; Ellison LK; Ramjeet M; Travassos LH; Jones NL; Girardin SE; Philpott DJ
    Immunity; 2013 Nov; 39(5):858-73. PubMed ID: 24238340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RIP2/RICK-dependent cytokine production upon Yersinia enterocolitica infection in macrophages with TLR4 deficiency.
    Jeong YJ; Kim CH; Kim JC; Oh SM; Lee KB; Park JH; Kim DJ
    Scand J Immunol; 2013 Nov; 78(5):401-7. PubMed ID: 23952047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs.
    Park JH; Kim YG; McDonald C; Kanneganti TD; Hasegawa M; Body-Malapel M; Inohara N; Núñez G
    J Immunol; 2007 Feb; 178(4):2380-6. PubMed ID: 17277144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2.
    Plantinga TS; Crisan TO; Oosting M; van de Veerdonk FL; de Jong DJ; Philpott DJ; van der Meer JW; Girardin SE; Joosten LA; Netea MG
    Gut; 2011 Sep; 60(9):1229-35. PubMed ID: 21406388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of nucleotide-binding oligomerization domain 2 by muramyl dipeptide negatively regulates Toll-like receptor 9-mediated colonic inflammation through the induction of deubiquitinating enzyme A expression.
    Masuta Y; Minaga K; Kurimoto M; Sekai I; Hara A; Omaru N; Okai N; Otsuka Y; Takada R; Yoshikawa T; Masaki S; Kamata K; Honjo H; Arai Y; Yamashita K; Kudo M; Watanabe T
    Int Immunol; 2023 Feb; 35(2):79-94. PubMed ID: 36171063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Crohn Disease-associated ATG16L1
    Gao P; Liu H; Huang H; Sun Y; Jia B; Hou B; Zhou X; Strober W; Zhang F
    Autophagy; 2022 Nov; 18(11):2561-2575. PubMed ID: 35220902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dual role for receptor-interacting protein kinase 2 (RIP2) kinase activity in nucleotide-binding oligomerization domain 2 (NOD2)-dependent autophagy.
    Homer CR; Kabi A; Marina-García N; Sreekumar A; Nesvizhskii AI; Nickerson KP; Chinnaiyan AM; Nuñez G; McDonald C
    J Biol Chem; 2012 Jul; 287(30):25565-76. PubMed ID: 22665475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nod2 and Rip2 contribute to innate immune responses in mouse neutrophils.
    Jeong YJ; Kang MJ; Lee SJ; Kim CH; Kim JC; Kim TH; Kim DJ; Kim D; Núñez G; Park JH
    Immunology; 2014 Oct; 143(2):269-76. PubMed ID: 24766550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2.
    Yang Y; Yin C; Pandey A; Abbott D; Sassetti C; Kelliher MA
    J Biol Chem; 2007 Dec; 282(50):36223-9. PubMed ID: 17947236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOD2 Modulates Serotonin Transporter and Interacts with TLR2 and TLR4 in Intestinal Epithelial Cells.
    Layunta E; Latorre E; Forcén R; Grasa L; Castro M; Arias MA; Alcalde AI; Mesonero JE
    Cell Physiol Biochem; 2018; 47(3):1217-1229. PubMed ID: 29913461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The crosstalk between TLR2 and NOD2 in Aspergillus fumigatus keratitis.
    Wu J; Zhang Y; Xin Z; Wu X
    Mol Immunol; 2015 Apr; 64(2):235-43. PubMed ID: 25549945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO.
    Abbott DW; Wilkins A; Asara JM; Cantley LC
    Curr Biol; 2004 Dec; 14(24):2217-27. PubMed ID: 15620648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of autophagic and innate immune responses by the Crohn's disease-associated
    Okai N; Watanabe T; Minaga K; Kamata K; Honjo H; Kudo M
    World J Gastroenterol; 2022 Jul; 28(26):3063-3070. PubMed ID: 36051337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.